LOS ANGELES, December 18, 2009 – Marlin Equity Partners (“Marlin”) is pleased to announce that it has acquired Liquent, Inc. (“Liquent”) from Thomson Reuters. Liquent is a leading provider of software and related regulatory and clinical services to the life sciences industry. The company’s solutions enable its customers to expedite the regulatory submissions and approval process, improve speed to market, control costs and increase productivity.
“Marlin was a valued partner throughout the process,” said John Bellizzi, Vice President of Thomson Reuters Professional Division. “The company’s industry knowledge, corporate divestiture expertise and ability to execute with speed and certainty allowed ...